Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.

Authors

null

Christian Grommes

Memorial Sloan Kettering Cancer Center, New York, NY

Christian Grommes , Jacqueline Stone , Craig Nolan , Elina Tsyvkin , Julia Wolfe , Ingo K. Mellinghoff , Lisa Marie DeAngelis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT02315326

Citation

J Clin Oncol 35, 2017 (suppl; abstr 7533)

DOI

10.1200/JCO.2017.35.15_suppl.7533

Abstract #

7533

Poster Bd #

295

Abstract Disclosures

Similar Posters

First Author: Feili Chen

First Author: Christian Grommes

First Author: Christian Grommes